Literature DB >> 19082715

Ghrelin and obestatin levels in type 2 diabetic patients with and without delayed gastric emptying.

Igor A Harsch1, Corinna Koebnick, Atingwa M Tasi, Eckhart Georg Hahn, Peter C Konturek.   

Abstract

Alterations in the neurohumoral regulation of the upper intestine may change rhythmicity and pattern of ghrelin and obestatin, the latter presumably antagonizing ghrelin effects. Five nongastroparetic diabetic patients and five with gastroparesis were investigated. Over 390 min including breakfast and lunch, ghrelin was significantly lower in patients with gastroparesis compared with in those without (P = 0.015). Ghrelin subsequent to lunch decreased significantly (P = 0.011) in patients without gastroparesis, but not in gastroparetic patients (P = 0.669). Obestatin was similar in both groups and unchanged. No significant differences in ghrelin-to-obestatin ratio were observed (P = 0.530). Loss of rhythmicity in the ghrelin levels of gastroparetic diabetics highlights the importance of integrity of the neurohumoral-intestinal axis. Stable diurnal obestatin levels do not support the concept of interaction between ghrelin and obestatin in terms of regulation of food intake and gastric emptying.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19082715     DOI: 10.1007/s10620-008-0622-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine.

Authors:  Thomas L Abell; Michael Camilleri; Kevin Donohoe; William L Hasler; Henry C Lin; Alan H Maurer; Richard W McCallum; Thomas Nowak; Martin L Nusynowitz; Henry P Parkman; Paul Shreve; Lawrence A Szarka; William J Snape; Harvey A Ziessman
Journal:  J Nucl Med Technol       Date:  2008-02-20

2.  Obestatin alters sleep in rats.

Authors:  Eva Szentirmai; James M Krueger
Journal:  Neurosci Lett       Date:  2006-06-23       Impact factor: 3.046

3.  Ghrelin stimulates gastric emptying and hunger in normal-weight humans.

Authors:  F Levin; T Edholm; P T Schmidt; P Grybäck; H Jacobsson; M Degerblad; C Höybye; J J Holst; J F Rehfeld; P M Hellström; E Näslund
Journal:  J Clin Endocrinol Metab       Date:  2006-06-13       Impact factor: 5.958

4.  Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake.

Authors:  Jian V Zhang; Pei-Gen Ren; Orna Avsian-Kretchmer; Ching-Wei Luo; Rami Rauch; Cynthia Klein; Aaron J W Hsueh
Journal:  Science       Date:  2005-11-11       Impact factor: 47.728

5.  Obestatin improves memory performance and causes anxiolytic effects in rats.

Authors:  Valeria P Carlini; Helgi B Schiöth; Susana R Debarioglio
Journal:  Biochem Biophys Res Commun       Date:  2006-12-04       Impact factor: 3.575

6.  Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis.

Authors:  Kishore V Gaddipati; Hrair P Simonian; Karen M Kresge; Guenther H Boden; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2006-07-26       Impact factor: 3.199

7.  Delayed gastric emptying and gastric autoimmunity in type 1 diabetes.

Authors:  Christophe E M De Block; Ivo H De Leeuw; Paul A Pelckmans; Dirk Callens; Emöke Máday; Luc F Van Gaal
Journal:  Diabetes Care       Date:  2002-05       Impact factor: 19.112

Review 8.  Ghrelin: update on a novel hormonal system.

Authors:  M Korbonits; A B Grossman
Journal:  Eur J Endocrinol       Date:  2004-08       Impact factor: 6.664

Review 9.  Disorders of gastrointestinal motility associated with diabetes mellitus.

Authors:  M Feldman; L R Schiller
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

10.  Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

Authors:  C M Borg; C W le Roux; M A Ghatei; S R Bloom; A G Patel; S J B Aylwin
Journal:  Br J Surg       Date:  2006-02       Impact factor: 6.939

View more
  7 in total

Review 1.  Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting.

Authors:  H P Parkman; M Camilleri; G Farrugia; R W McCallum; A E Bharucha; E A Mayer; J F Tack; R Spiller; M Horowitz; A I Vinik; J J Galligan; P J Pasricha; B Kuo; L A Szarka; L Marciani; K Jones; C R Parrish; P Sandroni; T Abell; T Ordog; W Hasler; K L Koch; K Sanders; N J Norton; F Hamilton
Journal:  Neurogastroenterol Motil       Date:  2009-12-09       Impact factor: 3.598

Review 2.  Gastroparesis: Medical and Therapeutic Advances.

Authors:  Christopher M Navas; Nihal K Patel; Brian E Lacy
Journal:  Dig Dis Sci       Date:  2017-07-18       Impact factor: 3.199

3.  Integrating GHS into the Ghrelin System.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Int J Pept       Date:  2010-03-18

Review 4.  Role of ghrelin in the pathophysiology of gastrointestinal disease.

Authors:  Cynthia K Cheung; Justin Che-Yuen Wu
Journal:  Gut Liver       Date:  2013-08-14       Impact factor: 4.519

Review 5.  Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Authors:  Elaine Cowan; Kerry J Burch; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2016-05-27       Impact factor: 8.739

Review 6.  Gastroparesis: concepts, controversies, and challenges.

Authors:  Klaus Bielefeldt
Journal:  Scientifica (Cairo)       Date:  2012-08-08

7.  Treatment with Obestatin-A Ghrelin Gene-Encoded Peptide-Reduces the Severity of Experimental Colitis Evoked by Trinitrobenzene Sulfonic Acid.

Authors:  Katarzyna Konarska; Jakub Cieszkowski; Zygmunt Warzecha; Piotr Ceranowicz; Anna Chmura; Beata Kuśnierz-Cabala; Krystyna Gałązka; Paweł Kowalczyk; Andrzej Miskiewicz; Thomas Jan Konturek; Michał Pędziwiatr; Artur Dembiński
Journal:  Int J Mol Sci       Date:  2018-06-01       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.